• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login

    Investing News NetworkYour trusted source for investing success

    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Longevity Market
    Longevity News
    Longevity Stocks
    • Longevity Market
    • Longevity News
    • Longevity Stocks
    longevity investing

    Cutera Announces Expansion of FDA Indications for the truSculpt® Body Contouring System

    Gabrielle Lakusta
    Jun. 13, 2018 09:18AM PST
    Longevity Investing

    CUTERA (Nasdaq:CUTR) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced the U.S. Food and Drug Administration (FDA) has granted clearance of an additional indication, for lipolysis or the breakdown of fat, on its premier non-surgical body sculpting system, truSculpt® 3D. As quoted in the press release: “TruSculpt’s approval for …

    CUTERA (Nasdaq:CUTR) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced the U.S. Food and Drug Administration (FDA) has granted clearance of an additional indication, for lipolysis or the breakdown of fat, on its premier non-surgical body sculpting system, truSculpt® 3D.

    As quoted in the press release:

    “TruSculpt’s approval for lipolysis is exciting in two ways,” said Dr. Ashish Bhatia, Associate Professor of Clinical Dermatology at Northwestern University’s Feinberg School of Medicine.  “First, it confirms how this technology works to reduce areas of unwanted fat, and second, we know that lipolysis of fat cells leads to lasting results, which is great for our patients.”

    “Today’s announcement is a major milestone for our Company and demonstrates our commitment in providing both our physician customers and patients one of the most effective body contouring solutions in the market today with clinically proven efficacy,” said James Reinstein, President and CEO of Cutera, Inc. “truSculpt 3D continues to demonstrate excellent market traction and is an important contributor to our planned revenue growth.  We will continue to develop technologies that advance the medical aesthetics industry and meet the needs of our customers and their patients.”

    Click here to read the full press release.

    nasdaq:cutrlongevity investing
    The Conversation (0)
    Go Deeper
    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Pink DNA strands.

    Sci-Fi Meets Reality: Lab-Grown Organs, Woolly Mice and 3D-Printed Hearts Redefining Life Sciences

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Longevity Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×